Y Yamaguchi Selected Research

Y Yamaguchi Research Topics

Disease

28	Neoplasms (Cancer) 03/2016 - 01/2000
9	Hemorrhage 12/2010 - 10/2000
6	Inflammation (Inflammations) 10/2020 - 06/2001
6	Wounds and Injuries (Trauma) 04/2010 - 10/2001
6	Type 2 Diabetes Mellitus (MODY) 01/2008 - 01/2000
5	Proteinuria 02/2010 - 06/2000
5	Chronic Hepatitis C 03/2004 - 01/2000
4	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2018 - 08/2014
4	Stomach Neoplasms (Stomach Cancer) 03/2016 - 09/2000
4	Necrosis 07/2011 - 11/2003
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2006 - 01/2000
3	Breast Neoplasms (Breast Cancer) 12/2019 - 06/2003
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2010 - 01/2000
3	Infections 11/2001 - 12/2000
3	Atherosclerosis 05/2001 - 01/2000
3	Glomerulonephritis 01/2001 - 11/2000
3	Ischemia 12/2000 - 01/2000
3	Reperfusion Injury 12/2000 - 01/2000
2	Obesity 10/2020 - 01/2004
2	Pain (Aches) 01/2017 - 02/2015
2	Rheumatoid Arthritis 01/2016 - 04/2005
2	Colonic Neoplasms (Colon Cancer) 11/2015 - 10/2000
2	Lung Neoplasms (Lung Cancer) 08/2015 - 02/2015
2	Atopic Dermatitis (Atopic Eczema) 08/2014 - 03/2011
2	Systemic Scleroderma (Systemic Sclerosis) 04/2013 - 04/2005
2	Nephrotic Syndrome (Syndrome, Nephrotic) 11/2010 - 07/2000
2	Insulin Resistance 02/2010 - 01/2000
2	Hypoglycemia (Reactive Hypoglycemia) 02/2010 - 01/2000
2	Hematuria 01/2010 - 06/2001
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2010 - 05/2000
2	Aspiration Pneumonia 01/2007 - 02/2006
2	Ulcer 06/2005 - 11/2004
2	Blister (Bulla) 04/2005 - 11/2004
2	Neoplasm Metastasis (Metastasis) 07/2004 - 09/2000
2	Obstructive Sleep Apnea 01/2004 - 08/2001
2	Colorectal Neoplasms (Colorectal Cancer) 11/2003 - 10/2000
2	Hepatitis 07/2001 - 06/2000
2	Pancreatitis 01/2001 - 08/2000

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 02/2016 - 06/2000
7	InterleukinsIBA 03/2011 - 08/2000
5	AutoantibodiesIBA 01/2020 - 01/2000
5	CytokinesIBA 08/2014 - 01/2000
5	EnzymesIBA 08/2014 - 04/2000
5	Insulin (Novolin)FDA Link 03/2006 - 01/2000
4	Immunoglobulin A (IgA)IBA 01/2014 - 01/2001
4	Complementary DNA (cDNA)IBA 05/2010 - 06/2003
4	AntibodiesIBA 02/2010 - 09/2001
4	Interleukin-2 (IL2)IBA 04/2006 - 08/2000
4	InterferonsIBA 03/2004 - 01/2000
3	Interleukin-6 (Interleukin 6)IBA 10/2020 - 11/2003
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 11/2004
3	Biological ProductsIBA 02/2015 - 01/2000
3	ImmunosorbentsIBA 08/2014 - 01/2001
3	CreatinineIBA 07/2011 - 01/2001
3	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2010 - 05/2001
3	Glucose (Dextrose)FDA LinkGeneric 02/2010 - 01/2000
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2006 - 08/2001
3	Messenger RNA (mRNA)IBA 02/2001 - 07/2000
3	Chemotactic FactorsIBA 12/2000 - 01/2000
2	LeptinIBA 10/2020 - 01/2003
2	Toll-Like Receptor 4IBA 01/2018 - 09/2015
2	Biomarkers (Surrogate Marker)IBA 06/2016 - 04/2013
2	Cadherins (E-Cadherin)IBA 03/2016 - 02/2016
2	Polysaccharides (Glycans)IBA 03/2016 - 09/2000
2	Adalimumab (Humira)FDA Link 01/2016 - 02/2015
2	TegafurIBA 11/2015 - 09/2000
2	ErbB Receptors (EGF Receptor)IBA 09/2015 - 02/2015
2	Epidermal Growth Factor (EGF)IBA 08/2015 - 02/2015
2	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 08/2015 - 02/2015
2	AgarIBA 02/2015 - 06/2001
2	PeriostinIBA 08/2014 - 04/2013
2	Uric Acid (Urate)IBA 04/2012 - 07/2011
2	CollagenIBA 11/2010 - 01/2000
2	Pharmaceutical PreparationsIBA 11/2010 - 05/2000
2	Insulin ReceptorIBA 02/2010 - 01/2000
2	B-insulinIBA 02/2010 - 01/2000
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2010 - 01/2000
2	SteroidsIBA 01/2010 - 06/2001
2	Hemoglobins (Hemoglobin)IBA 10/2006 - 08/2001
2	LipidsIBA 02/2006 - 01/2000
2	Capsules (Microcapsules)IBA 07/2004 - 01/2004
2	Estrogens (Estrogen)FDA Link 06/2004 - 06/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2004 - 08/2000
2	PicibanilIBA 11/2003 - 10/2000
2	Ethanol (Ethyl Alcohol)IBA 01/2003 - 07/2001
2	Phosphates (Orthophosphate)IBA 01/2003 - 01/2000
2	DNA (Deoxyribonucleic Acid)IBA 11/2001 - 01/2000
2	Oxidants (Oxidizing Agents)IBA 05/2001 - 01/2000
2	LectinsIBA 05/2001 - 01/2001
2	Dacarbazine (DIC)FDA LinkGeneric 04/2001 - 10/2000

Therapy/Procedure

19	Therapeutics 01/2011 - 01/2000
4	Occlusive Dressings (Occlusive Dressing) 04/2005 - 10/2001
3	Adjuvant Chemotherapy 11/2015 - 09/2000
3	Aftercare (After-Treatment) 01/2010 - 11/2000
3	Topical Administration 02/2006 - 10/2001
3	Immunotherapy 11/2003 - 10/2000
2	Bed Rest (Bedrest) 04/2005 - 11/2004
2	Debridement 04/2005 - 11/2004
2	Surgical Amputation (Amputations) 04/2005 - 11/2004
2	Kidney Transplantation 03/2001 - 01/2001